• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Preoperative Statins Can Protect Coronary Artery Bypass Graft Patients

Article

A collaborative study, conducted by researchers in the United Kingdom and in the United States, has found that statins could successfuly reduce mortality among patients undergoing coronary artery bypass graft (CABG), compared with several other medications.

A collaborative study, conducted by researchers in the United Kingdom and in the United States, has found that statins were the most successful in reducing mortality among patients undergoing coronary artery bypass graft (CABG), compared with several other medications. Analyzing data from 16,192 patients aged 40 years and older who underwent CABG surgery, the researchers found that administering statins prior to surgery reduced the risk of death folowing the procedure by 67%. The other medications used in the study did not show consistent effects.Ssimvastatin, the mostly commonly prescribed statin, exerted protective effects, reducing likelihood of death by 77%.

Read the complete article on ScienceDaily: http://bit.ly/1FYc8ra

Related Videos
Video 2 - "Adverse Events & Existing Treatment Options for Dry Eye Disease"
Overview of Dry Eye Disease (DED) Causes and Treatments
Video 12 - "Harnessing Indication-Specific Data on Biosimilars"
Video 11 - "An Overview of Biosimilar Extrapolation During FDA Approval"
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Video 1 - "Biomarkers and Molecular/ Genomic Testing in Genitourinary Cancers"
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.